Transparency Document
NCCN Guidelines for Older Adult Oncology V.1.2025
| Request Number | Guideline Page | Specific change request | Panel Decision | Comment | Institution Vote |
|---|---|---|---|---|---|
| 4027 |
OAO-F (4 OF 4), PDF Page 32
Cetirizine Hydrochloride for Injection Submission from TerSera on 05-21-2024 |
For the table entitled Risk Factors For the Development of Delirium in Older Patients With Cancer, we propose that in the Cancer-Related Factors column, the fifth row be altered as follows: “Toxicities from chemotherapy support (eg, first-generation antihistamines, steroids, antiemetics, anxiolytics, opioids.” | Change not made |
Yes: 0 No: 24 Abstain:0 Absent:9 |
|
| 4029 |
OAO-H (3 OF 7), Page 36 of PDF
Cetirizine Hydrochloride for Injection Submission from TerSera on 05-21-2024 |
For the table entitled Medications Commonly Used For Supportive Care That Are of Concern in Older Patients for the row entitled First-generation antihistamines, in the fourth column under Alternatives(s), we propose that a new bullet be added: “For the prevention of hypersensitivity reactions prior to the infusion of chemotherapy or biologic agents, consider IV cetirizine.” | Change not made |
Yes: 0 No: 24 Abstain:0 Absent:9 |